Close

The Advisory Board Company Reports Results For Quarter Ended September 30, 2015

Company Reports Revenue Growth of 39%, Contract Value Growth of 35%, and Announces $100M Increase to Share Repurchase Program

November 5, 2015 4:18 PM EST

WASHINGTON, Nov. 5, 2015 /PRNewswire/ -- The Advisory Board Company (NASDAQ: ABCO), a global technology, research, and services company providing the leading cloud-based comprehensive performance platform for the health care and higher education industries, today announced financial results for the quarter ended September 30, 2015. 

Highlights from the third quarter of 2015 are as follows (all comparisons, unless otherwise noted, are to the quarter ended September 30, 2014):

  • Revenue of $200.2 million, an increase of 39%
  • Contract value of $760.3 million, an increase of 35%
  • Adjusted EBITDA of $43.4 million, an increase of 71%
  • Non-GAAP earnings per diluted share of $0.33

Robert Musslewhite, Chairman and Chief Executive Officer of The Advisory Board Company, commented, "We are pleased with our performance for the quarter and the value we are delivering to our members as they face ongoing change and complexity in their markets. Our results reflect the powerful attributes of our business very clearly, with the combination of rapid top line growth along with even faster EBITDA growth, expanding margins, and solid cash generation. A keen focus on execution across the quarter allowed us to produce excellent operating outcomes, and we are well on pace to end the year with momentum and deliver key financial metrics within the guidance range we provided back in February."

Mr. Musslewhite continued, "Across these final two months of the year we are heavily focused on continuing to drive outstanding member impact and flawless execution in order to finish the important December quarter strong and to put ourselves in the best possible position for 2016 and beyond."

Third Quarter Financial Review

Revenue increased 39% to $200.2 million in the quarter ended September 30, 2015, up from $144.2 million for the quarter ended September 30, 2014. Contract value increased 35% to $760.3 million as of September 30, 2015, up from $561.6 million as of September 30, 2014.

Net income attributable to common stockholders was $1.9 million, or $0.04 per diluted share, for the quarter ended September 30, 2015, compared to net income attributable to common stockholders of $6.5 million, or $0.18 per diluted share, for the quarter ended September 30, 2014. Adjusted net income was $14.1 million for the quarter ended September 30, 2015, compared to $15.9 million for the quarter ended September 30, 2014. Non-GAAP earnings per diluted share was $0.33 for the quarter ended September 30, 2015, compared to $0.43 for the quarter ended September 30, 2014.

Adjusted EBITDA increased 71% to $43.4 million for the quarter ended September 30, 2015, up from $25.4 million for the quarter ended September 30, 2014.

Adjusted revenue, adjusted net income, non-GAAP earnings per diluted share, and adjusted EBITDA are non-GAAP financial measures.

Year-to-Date Financial Review

Revenue increased 33% to $564.7 million for the nine month period ended September 30, 2015, up from $424.0 million for the nine month period ended September 30, 2014. Adjusted revenue, which adjusts for the effect on revenue of fair value adjustments to acquired deferred revenue, increased 36% to $577.2 million for the nine month period ended September 30, 2015, up from $424.0 million for the nine month period ended September 30, 2014. Net loss attributable to common stockholders was $13.1 million, or $0.31 per diluted share, for the nine month period ended September 30, 2015, compared to net income attributable to common stockholders of $11.6 million, or $0.31 per diluted share, for the nine month period ended September 30, 2014. Adjusted EBITDA was $129.9 million for the nine month period ended September 30, 2015, up from $75.4 million for the nine month period ended September 30, 2014. Adjusted net income was $44.3 million for the nine month period ended September 30, 2015, up from $39.5 million for the nine month period ended September 30, 2014. Non-GAAP earnings per diluted share was $1.04 for the nine month period ended September 30, 2015, compared to $1.07 for the nine month period ended September 30, 2014.

Share Repurchase Authorization Increased by $100 Million

During the three months ended September 30, 2015, the Company repurchased approximately 678,000 shares of its common stock at a total cost of $33.0 million.  Since 2004, the Company has repurchased approximately 17.4 million shares of its common stock at a total cost of $431.8 million. 

The Company also announced that its Board of Directors authorized an increase in its share repurchase program of up to an additional $100 million of the Company's common stock, bringing the total amount authorized to be spent under the program to $550 million. Repurchases will continue to be made from time to time in the open market or in private transactions. The repurchase program does not obligate the Company to repurchase any specific number of shares and may be modified or discontinued at any time. The Company will fund its share repurchases with cash on hand and cash generated from operations. 

Outlook for Calendar Year 2015 

The Company is reaffirming its annual financial guidance. For calendar year 2015, the Company continues to expect:

  • Adjusted revenue to be in a range of approximately $780 million to $790 million
  • Adjusted EBITDA to be in a range of approximately $170 million to $175 million
  • Non-GAAP earnings per diluted share to be in a range of approximately $1.30 to $1.37
  • Adjusted effective tax rate to be in a range of approximately 45% to 47%

Conference Call Information

As previously announced, the Company will hold a conference call to discuss its third quarter performance this evening, November 5, 2015, at 5:30 p.m. Eastern Time. The conference call will be available via live webcast on the Company's website at www.advisory.com/IR. To participate by telephone, the dial-in number is 888.336.7150. Participants are advised to dial in at least five minutes prior to the call to register. The webcast will be archived for seven days from 8:00 p.m. Eastern Time on Thursday, November 5, 2015, until 11:00 p.m. Eastern Time on Thursday, November 12, 2015. The Company invites all interested parties to attend the conference call, including the lenders under the Company's senior secured credit facilities. 

A supplemental presentation of information complementary to the information presented in this release and that will be discussed on the conference call will be made available on the Company's website at www.advisory.com/IR prior to the conference call and will be archived for the same duration as the webcast.

About the Advisory Board Company

The Advisory Board Company is the leading provider of insight-driven technologyresearch, and services for organizations in transforming industries. Through its innovative membership model, the Company collaborates with more than 230,000 leaders at 5,200 member organizations to elevate performance and solve their most pressing problems. The Company provides strategic guidance, actionable insights, cloud-based software solutions, and comprehensive implementation and management services. For more information, visit www.advisory.com.

Non-GAAP Financial Measures 

This news release presents information about the Company's adjusted revenue, adjusted net income, non-GAAP earnings per diluted share, adjusted EBITDA, adjusted effective tax rate, and adjusted weighted average common shares outstanding-diluted, which are non-GAAP financial measures provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). A reconciliation of each of the foregoing historical non-GAAP financial measures to the most directly comparable historical GAAP financial measures is provided in the accompanying tables found at the end of this release for each of the fiscal periods indicated.

Caution Regarding Forward-Looking Statements

Statements in this news release that relate to future results and events are forward-looking statements and are based on the Company's expectations as of the date of this news release. In some cases, you can identify these statements by such forward-looking words as "anticipate," "believe," "estimate," "expect," "guidance," "intend," "may," "outlook," "plan," "potential," "should," "will," "would," or similar words or expressions. Forward-looking statements in this news release include the Company's expectations regarding its performance and results for fiscal 2015 with respect to adjusted revenue, adjusted EBITDA, non-GAAP earnings per diluted share, and adjusted effective tax rate. 

Actual results and events in future periods may differ materially from those expressed or implied by these forward-looking statements because of a number of risks, uncertainties, and other factors, including those relating to:  factors that adversely affect the financial condition of the health care and higher education industries; federal and state law and regulations governing the health care and higher education industries and our members' and our respective compliance with those applicable laws and regulations; the Company's ability to sustain high renewal rates on its memberships; maintenance of the Company's reputation and expansion of its name recognition; the Company's ability to offer new and valuable products and services; effects of competition; the Company's ability to maintain a highly-skilled workforce; unsuccessful design or implementation of software or delivery of consulting and management services; delays in generating revenue; effects of federal and state privacy and security laws and cyber attacks and other data security breaches; compliance with federal regulations governing electronic transactions; service disruptions and operational or security failures; ability to collect and maintain member and third party data and to obtain proper permissions and waivers for use and disclosure of information received from members or on their behalf; liability for failure to provide accurate information or for deficient submissions to third-party payors; compliance with federal and state laws governing healthcare fraud and abuse or reimbursement; maintenance of third-party providers and strategic alliances and entry into new alliances; licensing and integration of third-party technologies and data; protection of the Company's intellectual property; claims of infringement, misappropriation, or violation of proprietary rights of third parties; limitations associated with use of open source technology; changes to estimates and assumptions used to prepare the Company's consolidated financial statements; any significant increase in bad debt in excess of recorded estimates; failure to realize the anticipated benefits of the Royall acquisition; diversion of management's attention from operations by activities focused on the integration of Royall's business; business and financial risk associated with the pursuit of acquisition opportunities; delays in the delivery by Evolent Health to the Company of its financial statements; any significant impairment of the Company's goodwill; the Company's ability to realize a return on its strategic investments; the level of the Company's debt service obligations and restrictions on its operations under debt covenants; potential imposition of sales and use taxes on sales of the Company's services; the Company's ability to realize fully its deferred tax assets; inherent limitations in, and the potential impact of any failure to maintain, effective internal control over financial reporting; effects of issuance of additional capital stock; and provisions in the Company's charter and bylaws that could discourage takeover attempts.

This list of risks, uncertainties, and other factors is not complete. The Company discusses some of these matters more fully, as well as certain risk factors that could affect the Company's business, financial condition, results of operations, and prospects, in its filings with the Securities and Exchange Commission, including the Company's annual report on form 10-KT for the transition period ended December 31, 2014 and its quarterly reports on Form 10-Q and current reports on Form 8-K. These filings are available for review through the Securities and Exchange Commission's website at www.sec.gov. Any or all forward-looking statements the Company makes may turn out to be wrong, and can be affected by inaccurate assumptions the Company might make or by known or unknown risks, uncertainties, and other factors, including those identified in this news release. Accordingly, you should not place undue reliance on the forward-looking statements made in this news release, which speak only as of its date. The Company does not undertake to update any of its forward-looking statements, whether as a result of circumstances or events that arise after the date they are made, new information, or otherwise.

Reconciliation of Non-GAAP Financial Measures

This news release presents information about the Company's adjusted revenue, adjusted EBITDA, adjusted net income, non-GAAP earnings per diluted share, adjusted effective tax rate, and adjusted weighted average common shares outstanding-diluted, which are non-GAAP financial measures provided as a complement to the results provided in accordance with GAAP.

A reconciliation of each of the foregoing historical non-GAAP financial measures to the most directly comparable historical GAAP financial measures is provided below for each of the fiscal periods indicated. It is not practicable to provide a reconciliation of forecasted adjusted revenue, adjusted EBITDA, adjusted net income, non-GAAP earnings per diluted share, or adjusted effective tax rate to the most directly comparable GAAP financial measures because certain items required for the forecast of such GAAP financial measures, including fair value adjustments to acquisition-related earn-out liabilities, equity in income (loss) of unconsolidated entity, and gains and losses on investment in common stock warrants, cannot reasonably be estimated or predicted at this time.

 

 

Three Months Ended

Nine Months Ended

September 30,

September 30,

2015

2014

2015

2014

Revenue

$   200,238

$   144,220

$    564,694

$   424,041

Effect on revenue of fair value adjustments to acquisition-related deferred revenue

12,499

     Adjusted revenue

$   200,238

$   144,220

$    577,193

$   424,041

 

Three Months Ended

Nine Months Ended

September 30,

September 30,

2015

2014

2015

2014

Net income (loss) attributable to common stockholders

$    1,856

$   6,490

$    (13,117)

$     11,600

Effect on revenue of fair value adjustments to acquisition-related deferred revenue

12,499

Equity in loss of unconsolidated entities

3,289

1,197

1,668

6,078

Accretion of noncontrolling interest to redemption value

(150)

6,890

Provision for income taxes

7,156

710

12,066

11,540

Interest expense

5,450

16,333

Other expense (income), net

1,150

851

2,280

(591)

Loss on financing activities

17,398

Depreciation and amortization

18,494

9,679

55,067

27,225

Acquisition and similar transaction charges

6,610

268

Fair value adjustments to acquisition-related earn-out liabilities

(1,057)

(400)

(2,140)

(4,600)

Vacation accrual adjustment

850

(850)

850

Stock-based compensation expense

7,094

6,175

22,130

16,139

     Adjusted EBITDA

$    43,432

$   25,402

$    129,944

$    75,399

 

 

Three Months Ended

Nine Months Ended

September 30,

September 30,

2015

2014

2015

2014

Net income (loss) attributable to common stockholders

$    1,856

$    6,490

$    (13,117)

$     11,600

Effect of adjusted tax rate on net (loss) income

1,510

11,640

Effect on revenue of fair value adjustments to acquisition-related deferred revenue, net of adjusted tax rate

7,047

Equity in loss of unconsolidated entities

3,289

1,197

1,668

6,078

Accretion of noncontrolling interest to redemption value

(150)

6,890

Amortization of acquisition-related intangibles, net of adjusted tax rate

4,188

2,261

12,970

5,144

Loss on financing activities, net of adjusted tax rate

9,725

Acquisition and similar transaction charges, net of adjusted tax rate

3,704

162

Fair value adjustments to acquisition-related earn-out liabilities, net of adjusted tax rate

(572)

(366)

(1,191)

(2,949)

(Gain) loss on investment in common stock warrants, net of adjusted tax rate

(40)

108

Vacation accrual adjustment, net of adjusted tax rate

777

(475)

777

Stock-based compensation expense, net of adjusted tax rate

3,838

5,643

12,320

11,714

Adjusted net income

$    14,109

$    15,852

$   44,251

$    39,524

 

 

Three Months Ended

Nine Months Ended

September 30,

September 30,

2015

2014

2015

2014

Net income (loss) attributable to common shareholders per share - Diluted

$    0.04

$   0.18

$    (0.31)

$    0.31

Effect of adjusted tax rate on net (loss) income

0.04

0.27

Effect on revenue of fair value adjustments to acquisition-related deferred revenue, net of adjusted tax rate

0.16

Equity in loss of unconsolidated entities

0.08

0.03

0.04

0.16

Accretion of noncontrolling interest to redemption value

0.19

Amortization of acquisition-related intangibles, net of adjusted tax rate

0.10

0.06

0.31

0.15

Loss on financing activities, net of adjusted tax rate

0.23

Acquisition and similar transaction charges, net of adjusted tax rate

0.09

Fair value adjustments to acquisition-related earn-out liabilities, net of adjusted tax rate

(0.02)

(0.01)

(0.03)

(0.08)

Gain (loss) on investment in common stock warrants, net of adjusted tax rate

Vacation accrual adjustment, net of adjusted tax rate

0.02

(0.01)

0.02

Stock-based compensation expense, net of adjusted tax rate

0.09

0.15

0.29

0.32

Non-GAAP earnings per diluted share

$    0.33

$    0.43

$    1.04

$    1.07

 

 

Three Months Ended

Nine Months Ended

September 30,

September 30,

2015

2014

2015

2014

Effective tax rate

58.2%

8.6%

1,955.6%

32.0%

Effect on tax rate of Washington, D.C. tax law change, including write-off of Washington, D.C. income tax credits

(1,773.6%)

Effect on tax rate of loss on financing activities

(9.0%)

(17.9%)

Effect on tax rate of unconsolidated equity method investment related FIN 48 liability

Effect on tax rate of Royall acquisition costs and other acquisition-related tax items

(3.3%)

(119.7%)

     Adjusted effective tax rate

45.9%

8.6%

44.4%

32.0%

 

 

Three Months Ended

Nine Months Ended

September 30,

September 30,

2015

2014

2015

2014

Weighted average common shares outstanding – Diluted

42,788

36,703

41,900

36,983

Diluted shares outstanding (1)

525

Adjusted weighted average common shares outstanding – Diluted

42,788

36,703

42,425

36,983

(1)     For non-GAAP purposes the Company has net income, therefore has included diluted shares in its calculation of non-GAAP EPS.

 

 

 

THE ADVISORY BOARD COMPANY

 UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

 AND OTHER OPERATING STATISTICS

 (In thousands, except per share data)

 Three Months Ended

 Selected

 Nine Months Ended

 Selected

 September 30,

 Growth

 September 30,

 Growth

2015

2014

 Rates

2015

2014

 Rates

 Statements of Income

 Revenue (1)

$     200,238

$     144,220

38.8%

$     564,694

$      424,041

33.2%

 Cost of services, excluding depreciation and amortization (2) (3)

101,373

74,078

288,901

215,491

 Member relations and marketing (2)

30,792

26,792

90,893

79,780

 General and administrative (2) (4) (5)

30,678

24,573

93,205

66,028

 Depreciation and amortization (6)

18,494

9,679

55,067

27,225

      Operating income

18,901

9,098

36,628

35,517

 Other (expense) income

      Interest expense

(5,450)

-

(16,333)

-

      Other (expense) income, net

(1,150)

(851)

(2,280)

591

      Loss on financing activities

-

-

(17,398)

-

 Total other (expense) income, net

(6,600)

(851)

(36,011)

591

      Income before provision for income taxes

        and equity in loss of unconsolidated entities

12,301

8,247

617

36,108

 Provision for income taxes

(7,156)

(710)

(12,066)

(11,540)

 Equity in loss of unconsolidated entities

(3,289)

(1,197)

(1,668)

(6,078)

      Net income (loss) before allocation to noncontrolling interest

1,856

6,340

(13,117)

18,490

 Net loss and accretion to redemption value of noncontrolling interest

-

150

-

(6,890)

      Net income (loss) attributable to common stockholders

$         1,856

$         6,490

$     (13,117)

$        11,600

 Net (loss) income attributable to common stockholders per share

 Basic

$          0.04

$          0.18

$         (0.31)

$           0.32

 Diluted

$          0.04

$          0.18

$         (0.31)

$           0.31

 Weighted average common shares outstanding

 Basic

42,320

36,191

41,900

36,270

 Diluted

42,788

36,703

41,900

36,983

 Contract Value (at end of period) 

$     760,301

$     561,645

35.4%

 Percentages of Revenue

 Cost of services, excluding depreciation and amortization (2) (3)

50.6%

51.4%

51.2%

50.8%

 Member relations and marketing (2)

15.4%

18.6%

16.1%

18.8%

 General and administrative (2) (4) (5)

15.3%

17.0%

16.5%

15.6%

 Depreciation and amortization (6)

9.2%

6.7%

9.8%

6.4%

 Operating income

9.4%

6.3%

6.5%

8.4%

 Net income (loss) attributable to common stockholders

0.9%

4.5%

-2.3%

2.7%

(1)

Amounts include effect on revenue of fair value adjustments to acquisition-related deferred revenue, as follows:

Revenue 

-

-

(12,499)

-

(2)

Amounts include stock-based compensation, as follows:

Cost of services

2,423

1,916

6,881

5,387

Member relations and marketing

1,306

1,141

3,907

3,065

General and administrative

3,365

3,118

11,342

7,687

(3)

Amounts include fair value adjustments of acquisition-related earn-out liabilities, as follows:

Cost of services

(1,057)

(400)

(2,140)

(4,600)

(4)

Amounts include acquisition and transaction related costs, as follows:

General and administrative 

-

-

6,610

268

(5)

Amounts include reversal of vacation accrual charge related to change in fiscal year as follows:

General and administrative

-

850

(850)

850

(6)

Amounts include amortization of acquisition-related intangibles, as follows: 

Depreciation and amortization

7,740

2,473

23,320

7,201

 

 

THE ADVISORY BOARD COMPANY

 CONSOLIDATED BALANCE SHEETS

 (In thousands)

September 30,

December 31,

2015

2014

 (unaudited)

 ASSETS

 Current assets:

 Cash and cash equivalents

$            56,075

$            72,936

 Marketable securities, current

-

14,714

 Membership fees receivable, net

604,075

539,061

 Prepaid expenses and other current assets

25,388

23,254

 Deferred income taxes, current

16,159

14,695

 Total current assets

701,697

664,660

 Property and equipment, net

182,934

135,107

 Intangible assets, net

285,440

38,973

 Deferred incentive compensation and other charges

80,787

86,045

 Goodwill

842,859

186,895

 Investments in unconsolidated entities

3,077

9,316

 Other non-current assets

5,698

5,370

 Total assets

$       2,102,492

$       1,126,366

 LIABILITIES AND STOCKHOLDERS' EQUITY

 Current liabilities:

 Deferred revenue, current

$          586,360

$          501,785

 Accounts payable and accrued liabilities

76,295

80,284

 Accrued incentive compensation

27,851

32,073

 Debt, current

27,885

-

 Total current liabilities

718,391

614,142

 Deferred revenue, net of current portion

157,911

167,014

 Deferred income taxes, net of current portion

119,707

9,855

 Debt, net of current portion

529,422

-

 Other long-term liabilities

12,101

15,304

 Total liabilities

1,537,532

806,315

 Stockholders' equity:

 Common stock

419

361

 Additional paid-in capital

735,024

442,528

 Accumulated deficit

(169,030)

(122,920)

 Accumulated other comprehensive income

(1,453)

82

 Total stockholders' equity 

564,960

320,051

 Total liabilities and stockholders' equity

$       2,102,492

$       1,126,366

 

 

THE ADVISORY BOARD COMPANY

 UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

 (In thousands)

 Nine Months Ended September 30,

2015

2014

 Cash flows from operating activities:

 Net (loss) income before allocation to noncontrolling interest

$        (13,117)

$ 18,490

 Adjustments to reconcile net (loss) income before allocation to 

 noncontrolling interest to net cash provided by operating activities:

 Depreciation and amortization

55,067

27,225

 Loss on financing activities

17,398

-

 Amortization of debt issuance costs

983

-

 Deferred income taxes

9,912

11,018

 Excess tax benefits from stock-based awards

(2,804)

(5,011)

 Stock-based compensation expense

22,130

16,139

 Amortization of marketable securities premiums

-

1,664

 (Gain) loss on investment in common stock warrants

(70)

180

 Equity in loss of unconsolidated entities

1,668

6,078

 Changes in operating assets and liabilities (net of the effect of acquisition):

 Membership fees receivable

(35,774)

(10,876)

 Prepaid expenses and other current assets

7,978

(5,746)

 Deferred incentive compensation and other charges

2,977

7,248

 Other non-current assets

(258)

-

 Deferred revenue

57,172

(19,634)

 Accounts payable and accrued liabilities

(5,595)

(4,264)

 Acquisition-related earn-out payments

(2,198)

(3,073)

 Accrued incentive compensation

(4,222)

(8,659)

 Other long-term liabilities

(3,203)

(8,088)

 Net cash provided by operating activities

108,044

22,691

 Cash flows from investing activities:

 Purchases of property and equipment

(39,985)

(35,000)

 Capitalized external use software development costs

(2,965)

(3,871)

 Cash paid for acquisitions, net of cash acquired

(746,693)

(25,830)

 Cash paid for investment in unconsolidated entity

(3,006)

-

 Redemptions of marketable securities

14,714

85,959

 Purchases of marketable securities

-

(32,657)

 Net cash used in investing activities

(777,935)

(11,399)

 Cash flows from financing activities:

 Proceeds from debt, net

1,280,292

-

 Pay down of debt

(739,377)

-

 Debt issuance costs

(2,568)

-

 Proceeds from issuance of common stock, net of selling costs

148,786

-

 Proceeds from issuance of common stock from exercise of stock options

3,262

6,927

 Withholding of shares to satisfy minimum employee tax withholding

(6,058)

(7,735)

 Proceeds from issuance of stock under employee stock purchase plan

389

445

 Acquisition-related earn-out payments

(1,500)

-

 Excess tax benefits from stock-based awards

2,804

5,011

 Purchases of treasury stock

(33,000)

(41,772)

 Net cash provided by (used in) financing activities

653,030

(37,124)

 Net decrease in cash and cash equivalents

(16,861)

(25,832)

 Cash and cash equivalents, beginning of period

72,936

52,717

 Cash and cash equivalents, end of period

$          56,075

$26,885

 

Logo - http://photos.prnewswire.com/prnh/20110802/PH45999LOGO

           

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-advisory-board-company-reports-results-for-quarter-ended-september-30-2015-300173629.html

SOURCE The Advisory Board Company



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases

Related Entities

Stock Buyback, Earnings, Definitive Agreement